2017 - 2018 Academic Year
DEB/ECH 294 Schedule

2018 Winter Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

Jan. 12, 2018
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, DEB

Jan. 19, 2018
LSA 1022

Bio-Based Fuels & Chemicals: Technology Development and Commercialization at JBEI (Joint BioEnergy Institute)
Peter Matlock, PhD
Director, Technology Commercialization

JBEI: Joint BioEnergy Institute, Emeryville, CA

Jan. 26th, 2018
LSA 1022

Converging trends in healthcare: Cross-sector skills for a changing marketplace
Todd Meyerrose, PhD (UCD Alumn)
Vice President

P4G Capital,
San Francisco, CA

Feb 2, 2018
LSA 1022

Next Generation Therapeutics: Designing in CQAs
Vally Kommineni, PhD
Senior Scientist
iBio CMO, Bryan TX

Feb. 9, 2018
LSA 1022

Antimicrobial Proteins Made in Plants as Novel Food Safety Interventions
Daniel Tusé, Ph.D
Owner and Managing Director
DT/Consulting Group, Sacramento, CA


Feb. 16, 2018
LSA 1022

Advanced Microbial Selection (AMS): a unique discovery strategy for microbes that improve plant health and productivity
Susan Turner, PhD
Senior Vice President, Research & Discovery

BioConsortia, Inc., Davis, CA

Feb 23, 2018

Title: TBD
Alan Perlstein, PhD
CEO

MiraculeX, Inc., San Francisco, CA


March 2, 2018

LSA 1022

If you liked it, you should have put a seq on it
Olga Botvinnik, PhD
Bioinformatics Data Scientist
Chan Zuckerberg Biohub,
San Francisco, CA

March 9, 2018
LSA 1022

Protein-based Drug Discovery and Development at NGM Biopharmaceuticals
Shelley Starck, PhD
Senior Scientist
NGM Biopharmaceuticals, San Francisco, CA

March 16, 2018
LSA 1022

 


 

 

Applying your PhD to Life Science Consulting
Garrick Yuen, PhD
(DEB Alum)
Senior Associate
BluePrint Research Group, San Francisco, CA


 

 


   

Reports are due by 5 pm on Friday, March 23, 2018




 

2017 Fall Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

Sept. 29, 2017
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

Oct. 6, 2017
LSA 1022

Big Bang! Kickoff
Niki Peterson, Program Manager, Child Family Institute for Innovation & Entrepreneurship,
Marc Facciotti, PhD, Associate Professor & Assistant Director, TEAM Prototyping Facility Department of Biomedical Engineering, UC Davis Genome Center

Oct. 13, 2017
LSA 1022

What is Intellectual Property?
Maris Apse, PhD, Intellectual Property Officer
UC Davis Innovation Access, UC
Davis

Oct. 20, 2017
LSA 1022

How to Translate Your Research and Ideas Into a Startup
Zane Starkewolfe, PhD (Former DEB Student)
Associate Director,
New Venture Resources, UC Davis

Oct. 27, 2017
LSA 1022

A Tale of Two Drugs
Beiyao Zheng, PhD
, Senior Director of Biometrics
CytomX Therapeutics, Inc.
, San Francisco, CA

Nov. 3, 2017
LSA 1022

Building a Biotech: A Journey From Sweeteners to Schedule 1 Narcotics
Brandon Zipp, PhD, Director of Research and Development, Scientific Co-Founder

Vitality Biopharma Inc, Los Angeles, CA Sponsored by BMCDB Graduate Group

Nov 10, 2017

Veterans Day - Holiday

Nov 17, 2017

LSA 1022

Producing Profitable Probiotic Products Professionally: Progressing From PhD Projects to Packaged Pills
Zachary Lewis, PhD
(Former DEB Student) Scientist II - Renew Life
The Chlorox Company,
Pleasanton, CA

Nov. 24, 2017
LSA 1022

Thanksgiving - Holiday

Dec 1, 2017
LSA 1022

 



Dec 8, 2017
LSA 1022


 

 

From Genetics to Therapeutics - Leveraging 23andMe Data to Identify Drug Targets
Erik Karrer, PhD (UC Davis Alum) Director, Drug Discovery
Presentation HERE
23andMe Inc,
San Francisco Bay area, CA


Innovating Technologies for Broader and Safer Redirected T-cell Therapies of Cancer
Cheng Liu, PhD
Founder and CEO
Eureka Therapeutics Inc, San Francisco Bay area, CA


 

 


   

Reports are due by 5 pm on Friday, December 15, 2017




 

2017 Spring Schedule

All seminars are scheduled from 11:00am to 12:00pm unless otherwise stated

April 7, 2017
LSA 1022

Organizational Meeting
Dr. Judy Kjelstrom - Co-Instructor, Biotechnology Program & DEB Program Coordinator
Prof. Karen McDonald - Co-Instructor, ECH
Co-Prof. Ray Rodriguez - Co-Instructor, MCB

April 14, 2017
LSA 1022

The Antibody Discovery Paradigm
Aaron K Sato, PhD, Chief Scientific Officer LakePharma, Belmont, CA

April 21, 2017
LSA 1022

Advanced Microbial Selection (AMS): a unique discovery strategy for microbes that improve plant health and productivity
Susan Turner, PhD, Senior Vice President, Research & Discovery
BioConsortia Inc.,
Davis

April 28, 2017
LSA 1022

Turning Ideas Into Medicines: Early Drug Discovery in a Global Pharmaceutical Company
Richard Myers, PhD
Sr. Scientist, Target ID & Validation,
Takeda Pharmaceuticals, San Diego
Presentation Here

May 5, 2017
LSA 1022

From Galaxy Evolution to the Genomics Revolution: Perspectives of a Self-taught Bioinformatician
Jason Harris, PhD

Director, Bioinformatics Engineering, Personalis Inc.
,San Francisco, CA

May 12, 2017
LSA 1022

Why entrepreneurship makes sense
Benjamin R. Wang, MD, Founder and Chief Medical Officer
, NeVap Inc., Emeryville

May 19, 2017
Putah Creek Lodge

ESTEME Colloquium

Navigating a STEM Career in the Pharmaceutical Industry
Donna M. Dambach, VMD, PhD, Diplomate, ACVP, Senior Director, Head of Toxicology, Safety Assessment, Genentech, Inc., San Francisco, CA

May 26, 2017LSA 1022

Putting the D in Biopharmaceutical Research & Development
Matthew Schenauer, PhD

Senior Research Scientist, Gilead Sciences,
Oceanside

June 2, 2017
LSA 1022


 

 

Bio-Based Fuels & Chemicals: Technology Development Development and Commercialization at JBEI (Joint BioEnergy Institute)
Peter Matlock, PhD, Director, Technology Commercialization JBEI: Joint BioEnergy Institute, JBEI: Joint BioEnergy Institute, Emeryville

 


 

 


   

Reports are due by 5 pm on Friday, June 15, 2017